Connection

John Colwell to Aspirin

Back to Details
This is a "connection" page, showing publications John Colwell has written about Aspirin.
John Colwell
Connection Strength
2.697
Aspirin
  1. Does aspirin use reduce cardiovascular risk in diabetes? Nat Rev Endocrinol. 2009 Apr; 5(4):188-90.
    View in: PubMed
    Score: 0.288
  2. An appraisal of aspirin therapy in diabetes. Curr Diab Rep. 2006 Dec; 6(6):409-10.
    View in: PubMed
    Score: 0.245
  3. Aspirin for the primary prevention of cardiovascular events. Drugs Today (Barc). 2006 Jul; 42(7):467-79.
    View in: PubMed
    Score: 0.238
  4. Is aspirin effective in diabetic patients? Yes. J Thromb Haemost. 2005 Dec; 3(12):2612-4.
    View in: PubMed
    Score: 0.228
  5. Aspirin therapy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S72-3.
    View in: PubMed
    Score: 0.200
  6. Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care. 2003 Dec; 26(12):3349-50.
    View in: PubMed
    Score: 0.199
  7. Aspirin therapy in diabetes. Diabetes Care. 2003 Jan; 26 Suppl 1:S87-8.
    View in: PubMed
    Score: 0.187
  8. Aspirin and risk of hemorrhagic stroke. JAMA. 1999 Aug 25; 282(8):731-2; author reply 732-3.
    View in: PubMed
    Score: 0.148
  9. Aspirin therapy in diabetes. Diabetes Care. 1997 Nov; 20(11):1767-71.
    View in: PubMed
    Score: 0.130
  10. Aspirin therapy in diabetes mellitus. Diabetologia. 1997 Jul; 40(7):867.
    View in: PubMed
    Score: 0.127
  11. Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86.
    View in: PubMed
    Score: 0.078
  12. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun; 33(6):1395-402.
    View in: PubMed
    Score: 0.078
  13. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22; 121(24):2694-701.
    View in: PubMed
    Score: 0.078
  14. V.A. Cooperative Study of antiplatelet agents in diabetic patients after amputation for gangrene: unobserved, sudden, and unexpected deaths. J Diabet Complications. 1989 Oct-Dec; 3(4):191-7.
    View in: PubMed
    Score: 0.075
  15. Antiplatelet agents and diabetic vascular disease. Trans Am Clin Climatol Assoc. 1987; 98:119-27.
    View in: PubMed
    Score: 0.062
  16. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care. 1986 Mar-Apr; 9(2):140-8.
    View in: PubMed
    Score: 0.058
  17. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. Horm Metab Res Suppl. 1985; 15:69-73.
    View in: PubMed
    Score: 0.054
  18. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003 Jul; 26(7):2181-8.
    View in: PubMed
    Score: 0.048
  19. Treatment for the procoagulant state in type 2 diabetes. Endocrinol Metab Clin North Am. 2001 Dec; 30(4):1011-30.
    View in: PubMed
    Score: 0.043
  20. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4.
    View in: PubMed
    Score: 0.033
  21. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes. 1996 Jul; 45 Suppl 3:S87-90.
    View in: PubMed
    Score: 0.030
  22. VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis. Haemostasis. 1986; 16(6):433-8.
    View in: PubMed
    Score: 0.014
  23. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism. 1985 Dec; 34(12 Suppl 1):32-6.
    View in: PubMed
    Score: 0.014
  24. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics. Control Clin Trials. 1984 Jun; 5(2):165-83.
    View in: PubMed
    Score: 0.013
  25. Atherosclerosis in diabetes mellitus. J Chronic Dis. 1981; 34(1):1-4.
    View in: PubMed
    Score: 0.010
  26. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr; 44(4):521-6.
    View in: PubMed
    Score: 0.010
  27. Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31.
    View in: PubMed
    Score: 0.007
  28. Increased platelet aggregation in early diabetus mellitus. Ann Intern Med. 1975 Jun; 82(6):733-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.